$DNA is in trouble now after a very weak earnings yesterday.
Revenue dropped, 2024 outlook slashed and there are plans to start cost cutting which usually means downsizing...not what you would want to see from a growth stock.
We can see that the damage was starting to unfold over the last few months after 4 negative earnings reports in a row put this in a downward channel and when the blue line was lost, especially on the retest of the blue line and the 50 Day MA where I have circled, its destiny was sealed next.
$DNA managed need to try and turn this around before their next earnings report but now that the price is below $1, something will need to happen or they are at risk of being delisted.